Showing results (161-170 of 299) with videos related to

Sort By:
Pageof 30
JACC. Cardiooncology|March 6, 2023
Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for CancerSarah Waliany, Jennifer Caswell-Jin, Fauzia Riaz, et al.
Clinical Lung Cancer|February 25, 2024
HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US Electronic Health Records Database Analysis of Clinical Characteristics, Treatment Practice Patterns, and OutcomesSarah Waliany, Joel W Neal, Nicole Engel-Nitz, et al.
Cancer Discovery|May 3, 2015
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR InhibitorZofia Piotrowska, Matthew J Niederst, Chris A Karlovich, et al.
Nature Communications|June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Molecular profiling of single circulating tumor cells from lung cancer patientsSeung-Min Park, Dawson J Wong, Chin Chun Ooi, et al.
JCO Precision Oncology|April 9, 2026
Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung CancerRika Terashima, Judy Fan, Fatma Gunturkun, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2011
A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumorsSukhmani K Padda, Yelena Krupitskaya, Laveena Chhatwani, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Oncotarget|June 17, 2021
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic typeSukhmani K Padda, Yesim Gökmen-Polar, Jessica A Hellyer, et al.
JNCI Cancer Spectrum|October 6, 2021
Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort StudySophia J Luo, Eunji Choi, Jacqueline V Aredo, et al.
Pageof 30